Form 4 for ESLA Estrella Immunopharma, Inc.

Accepted 2022-03-17 00:00:00 ET · period of report 2022-03-04 · accession 0001104659-22-035068 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
E	2022-03-17	2022-03-04	ESLA	Li Jianwei	Co-CEO, Dir, 10%	P - Purchase	$314,700.00	+142.0K	1.25M	+13%	—

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-03-04	P	A	141,970	$314,700.00	1,253,730	D	—	—	(F2) Mr. Jianwei Li is the manager of the Sponsor. As such Mr. Li may be deemed to have beneficial ownership of the shares of Common Stock held directly by the Sponsor. Mr. Li disclaims beneficial ownership over any securities owned by the Sponsor in which he does not have any pecuniary interest. (F1) Mr. Jianwei Li beneficially owns 141,970 shares of Common Stock directly and may be deemed to beneficially own 1,111,760 shares of Common Stock held by TradeUP Acquisition Sponsor LLC (the "Sponsor"). As a result, Mr. Jianwei Li in aggregate beneficially owns 1,253,730 shares of Common Stock.